It was one year ago this month that Ashley McEvoy announced her surprising resignation as worldwide chair of J&J MedTech. She ...

Johnson & Johnson MedTech has concluded subject enrolment for the pilot phase of the OMNY-AF study of the investigational OMNYPULSE Platform for treating symptomatic paroxysmal atrial fibrillation ...

Johnson & Johnson MedTech today announced the completed enrollment of the pilot phase of a clinical trial for its Omnypulse ...

Jones, who has led connectivity solutions for J&J’s surgical robots, announced his departure on LinkedIn.

We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other pharma stocks.

Johnson & Johnson MedTech’s Abiomed announced that its compressible, expandable heart pump has cleared a pivotal trial, and ...

Shockwave Medical, Inc., part of Johnson & Johnson MedTech has announced the completion of enrollment in EMPOWER CAD, the ...

Results were presented at Transcatheter Cardiovascular Therapeutics (TCT) 2024 conference from the first completed pivotal ...

Let me take a moment to congratulate our award winners for 2024. Our Visionary Award was presented to Walmart. Squint received the Start-Up Award.

Maria Sainz offers advice for medical device developers from her decades-long career in medtech C-suites and boardrooms.

Results were presented at Transcatheter Cardiovascular Therapeutics, or TCT, 2024 conference from the first completed pivotal trial on patients ...

At Advamed’s The Medtech Conference last week, the new director of the Food and Drug Administration’s device center, Michelle Tarver, shared the agency’s priorities and upcoming directives.